Ansofaxine hydrochloride
CAS No. 916918-84-8
Ansofaxine hydrochloride ( LY03005 | LPM570065 )
产品货号. M20130 CAS No. 916918-84-8
Ansofaxine (LY03005; LPM570065) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂(IC50 分别为:723、763 和 491 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1169 | 有现货 |
|
| 10MG | ¥1891 | 有现货 |
|
| 25MG | ¥3329 | 有现货 |
|
| 50MG | ¥4771 | 有现货 |
|
| 100MG | ¥6237 | 有现货 |
|
| 200MG | ¥8577 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1074 | 有现货 |
|
生物学信息
-
产品名称Ansofaxine hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ansofaxine (LY03005; LPM570065) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂(IC50 分别为:723、763 和 491 nM)。
-
产品描述Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).(In Vivo):Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
-
体外实验——
-
体内实验Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
-
同义词LY03005 | LPM570065
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体serotonin reuptake| dopamine reuptake| norepinephrine reuptake
-
研究领域Neurological Disease
-
适应症Major depressive disorder
化学信息
-
CAS Number916918-84-8
-
分子量417.97
-
分子式C24H32ClNO3
-
纯度>98% (HPLC)
-
溶解度DMSO: 30 mg/mL (71.77 mM)
-
SMILESCl.CN(C)CC(c1ccc(OC(=O)c2ccc(C)cc2)cc1)C1(O)CCCCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Zhang R et al. The effects of LPM570065 a novel triple reuptake inhibitor on extracellular serotonin dopamineand norepinephrine levels in rats. PLoS One. 2014 Mar 10;9(3):e91775.
产品手册
关联产品
-
Bromperidol
Bromperidol (R-11333) 具有抗精神病活性,与中枢多巴胺受体 D2 (dopamine receptors D2) 具有高亲和力。Bromperidol 与 Spectinomycin 可协同杀灭分枝杆菌 (Mycobacteria)。
-
Azaphen
Azaphen 是血清素再摄取抑制剂,具有抗抑郁作用和镇静作用,表明具有抗组胺活性。
-
Perospirone hydrochl...
Perospirone (SM-9018 free base) 是具有口服活性的 5-HT2A 受体 (Ki=0.6 nM) 和多巴胺 D2 受体 (Ki=1.4 nM) 的拮抗剂,也是 5-HT1A 受体 (Ki=2.9 nM) 的部分激动剂。
021-51111890
购物车()
sales@molnova.cn

